Schroder Investment Management Group’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$61.9M Buy
4,342,883
+774,305
+22% +$7.47M 0.04% 305
2026
Q1
$25.7M Sell
3,568,578
-449,010
-11% -$4.72M 0.02% 485
2025
Q4
$49.1M Buy
4,017,588
+535,585
+15% +$5.78M 0.04% 311
2025
Q3
$27.1M Sell
3,482,003
-240,870
-6% -$1.69M 0.02% 453
2025
Q2
$27.2M Sell
3,722,873
-587,332
-14% -$4.74M 0.02% 448
2025
Q1
$41.5M Buy
4,310,205
+509,990
+13% +$6.37M 0.04% 327
2024
Q4
$62.6M Sell
3,800,215
-419,612
-10% -$6.52M 0.06% 254
2024
Q3
$61.2M Buy
4,219,827
+21,195
+0.5% +$332K 0.06% 250
2024
Q2
$58.2M Buy
4,198,632
+1,094,529
+35% +$15.5M 0.06% 248
2024
Q1
$48.8M Buy
3,104,103
+623,679
+25% +$9.63M 0.06% 292
2023
Q4
$40.1M Sell
2,480,424
-32,883
-1% -$538K 0.05% 331
2023
Q3
$30.9M Buy
2,513,307
+529,178
+27% +$7.87M 0.05% 352
2023
Q2
$31.9M Sell
1,984,129
-348,305
-15% -$5.74M 0.05% 378
2023
Q1
$40.6M Buy
2,332,434
+30,047
+1% +$428K 0.06% 321
2022
Q4
$21.3M Buy
2,302,387
+574,815
+33% +$5.36M 0.03% 441
2022
Q3
$14.9M Sell
1,727,572
-568,111
-25% -$5.64M 0.02% 517
2022
Q2
$18.7M Sell
2,295,683
-103,555
-4% -$989K 0.03% 483
2022
Q1
$29.2M Buy
2,399,238
+553,019
+30% +$11.6M 0.04% 406
2021
Q4
$63M Buy
1,846,219
+838,228
+83% +$32.8M 0.08% 247
2021
Q3
$48.6M Buy
+1,007,991
New +$46.7M 0.07% 271

Other funds holding NEO

Schroder Investment Management Group's NEO Position: Q2 2026 in Review

Schroder Investment Management Group increased its NeoGenomics (NEO) stake by 22% in Q2 2026, buying an estimated $7.47M and bringing the position to 4,342,883 shares worth $61.9M. The position accounts for 0.04% of the portfolio, ranked #305.

Schroder Investment Management Group first reported a position in NEO in Q3 2021 and has held it in 20 quarters since. The position peaked at $63M in Q4 2021. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Schroder Investment Management Group held 4,342,883 shares of NeoGenomics worth $61.9M as of Q2 2026.
  • Schroder Investment Management Group bought 774,305 NeoGenomics shares in Q2 2026, an estimated $7.47M.
  • NeoGenomics made up 0.04% of Schroder Investment Management Group's portfolio in Q2 2026, its #305 holding.
  • Schroder Investment Management Group first reported a position in NeoGenomics in Q3 2021 and has held it in 20 quarters since.
  • Schroder Investment Management Group's NeoGenomics position peaked at $63M in Q4 2021.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.